Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00429988 · ClinicalTrials.gov registry record

Study of Ductal Lavage in Women at High Risk for Breast Cancer

A clinical trial of Breast Cancer, sponsored by University of California, San Francisco.

Completed
Registry status
30
Enrollment target
1
Study location

NCT00429988: Completed study of Breast Cancer, sponsored by University of California, San Francisco.

NCT00429988 is a study of Breast Cancer that has completed, run by University of California, San Francisco. The registered enrollment target is 30 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00429988, a study of Breast Cancer, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: Collecting samples of fluid using ductal lavage and nipple aspiration from participants at high risk for breast cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This clinical trial is using ductal lavage to collect fluid from women at high risk for breast cancer.

Conditions Studied

Interventions

  • OTHER cytology specimen collection procedure
  • GENETIC polymerase chain reaction
  • OTHER immunohistochemistry staining method
  • GENETIC fluorescence in situ hybridization
  • GENETIC proteomic profiling

Study Locations (1)

California

  • UCSF Comprehensive Cancer Center - San Francisco

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2002-08
Est. Completion 2004-06

What the finished NCT00429988 record still lists

NCT00429988 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 5 interventions - of which cytology specimen collection procedure is the first listed.

NCT00429988 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00429988 about?

NCT00429988 is a clinical study titled "Study of Ductal Lavage in Women at High Risk for Breast Cancer". RATIONALE: Collecting samples of fluid using ductal lavage and nipple aspiration from participants at high risk for breast cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This clinical trial is usi...

What is the current status of trial NCT00429988?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2002-08. Estimated completion is 2004-06.

What conditions does trial NCT00429988 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT00429988?

The interventions under investigation include: cytology specimen collection procedure (OTHER), polymerase chain reaction (GENETIC), immunohistochemistry staining method (OTHER), fluorescence in situ hybridization (GENETIC), proteomic profiling (GENETIC).

Who is sponsoring clinical trial NCT00429988?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00429988 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00429988's enrollment target sits among peer trials

30 955th of 1224 higher than 227 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00429988, the US trial registry maintained by the National Library of Medicine. NCT00429988 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.